Back to Results
First PageMeta Content
Pharmacology / FDA Warning Letter / Food and Drug Administration Modernization Act / Food and Drug Administration / Pharmaceutical sciences / Clinical research


This document is scheduled to be published in the Federal Register onand available online at http://federalregister.gov/a, and on FDsys.govP DEPARTMENT OF HEALTH AND HUMAN SERVICES
Add to Reading List

Document Date: 2015-05-06 08:46:33


Open Document

File Size: 137,62 KB

Share Result on Facebook

City

Washington / DC / /

Company

Special Medical Programs / Sprout Pharmaceuticals Inc. / /

/

Facility

FDA White Oak Campus / /

/

IndustryTerm

treatment of hypoactive sexual desire disorder / transportation / /

MedicalCondition

hypoactive sexual desire disorder / /

Organization

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration / Drug Safety and Risk Management Advisory Committee / Bone / Reproductive / and Urologic Drugs Advisory Committee / FDA / Risk Management Advisory Committee / Center for Drug Evaluation and Research / Meeting AGENCY / /

Person

Jill Hartzler Warner / Silver Spring / /

/

Position

Associate Commissioner / /

ProvinceOrState

Maryland / /

URL

http /

SocialTag